116 related articles for article (PubMed ID: 1175689)
1. Prevention of 6-hydroxydopamine neurotoxicity.
Cohen G; Allis B; Winston B; Mytilineou C; Heikkila R
Eur J Pharmacol; 1975 Aug; 33(1):217-21. PubMed ID: 1175689
[TBL] [Abstract][Full Text] [Related]
2. Destruction of sympathetic nerve terminals by 6-hydroxydopamine: protection by 1-phenyl-3-(2-thiazolyl)-2-thiourea, diethyldithiocarbamate, methimazole, cysteamine, ethanol and n-butanol.
Cohen G; Heikkila RE; Allis B; Cabbat F; Dembiec D; MacNamee D; Mytilineou C; Winston B
J Pharmacol Exp Ther; 1976 Nov; 199(2):336-52. PubMed ID: 185360
[TBL] [Abstract][Full Text] [Related]
3. The neurotoxicity of 5,7-dihydroxytryptamine in the mouse atrium: protection by 1-phenyl-3-(2-thiazolyl)-2-thiourea and by ethanol.
Allis B; Cohen G
Eur J Pharmacol; 1977 Jun; 43(3):269-72. PubMed ID: 872880
[TBL] [Abstract][Full Text] [Related]
4. Effects of drugs on the 6-hydroxydopamine induced degeneration of adrenergic nerves.
Jonsson G; Malmfors T; Sachs C
Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):543-56. PubMed ID: 5034513
[No Abstract] [Full Text] [Related]
5. Correlation of norepinephrine content with observations of adrenergic nerves after a single dose of 6-hydroxydopamine in the rat.
Goldman H; Jacobowitz D
J Pharmacol Exp Ther; 1971 Jan; 176(1):119-33. PubMed ID: 5569629
[No Abstract] [Full Text] [Related]
6. Protection by desipramine of 6-hydroxydopamine induced damage to adrenergic nerve terminals in mouse heart.
Bonagura V; Cassebaum L; Dangman K; Freund J; Cabbat F; Dembiec D; Heikkila R; Cohen G
Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):163-71. PubMed ID: 4671960
[No Abstract] [Full Text] [Related]
7. Evidence for degeneration of sympathetic nerve terminals caused by the ortho- and para-quinones of 6-hydroxydopamine.
Heikkila RE; Mytilineou C; Côté L; Cohen G
J Neurochem; 1973 May; 20(5):1345-50. PubMed ID: 4716829
[No Abstract] [Full Text] [Related]
8. An electron microscopic study of selective, acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine.
Tranzer JP; Thoenen H
Experientia; 1968 Feb; 24(2):155-6. PubMed ID: 4384505
[No Abstract] [Full Text] [Related]
9. Studies on the mechanisms of 6-hydroxydopamine cytotoxicity.
Jonsson G
Med Biol; 1976 Dec; 54(6):406-20. PubMed ID: 1034180
[TBL] [Abstract][Full Text] [Related]
10. Neurochemical properties of adrenergic nerves regenerated after 6-hydroxydopamine.
Jonsson G; Sachs C
J Neurochem; 1972 Nov; 19(11):2577-85. PubMed ID: 5086245
[No Abstract] [Full Text] [Related]
11. Degeneration and regrowth of adrenergic nerve fibers in the rat peripheral tissues after 6-hydroxydopamine.
de Champlain J
Can J Physiol Pharmacol; 1971 Apr; 49(4):345-55. PubMed ID: 5124933
[No Abstract] [Full Text] [Related]
12. Alloxan and 6-hydroxydopamine: cellular toxins.
Cohen G; Heikkila RE
Methods Enzymol; 1984; 105():510-6. PubMed ID: 6328201
[No Abstract] [Full Text] [Related]
13. Fine structural identification of a reserpine-resistant norepinephrine store in adrenergic nerve terminals in guinea-pig atria.
Van Orden LS; Schaefer JM; Antonaccio MJ; Smith CB
J Pharmacol Exp Ther; 1974 Mar; 188(3):668-75. PubMed ID: 4131521
[No Abstract] [Full Text] [Related]
14. Degenerative and nondegenerative effects of 6-hydroxydopamine on adrenergic nerves.
Jonsson G; Sachs C
J Pharmacol Exp Ther; 1972 Mar; 180(3):625-35. PubMed ID: 4335111
[No Abstract] [Full Text] [Related]
15. Degeneration and regeneration of adrenergic nerves in mesenteric blood vessels, iris and atrium of the rat after 6-hydroxydopamine injection.
Lorez HP; Kuhn H; Bartholini G
J Neurocytol; 1975 Apr; 4(2):157-76. PubMed ID: 1123654
[TBL] [Abstract][Full Text] [Related]
16. [On the possibility of chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine (6-OH-DA)].
Thoenen H; Tranzer JP
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):212-3. PubMed ID: 4239240
[No Abstract] [Full Text] [Related]
17. Degeneration of adrenergic nerves produced by 6-hydroxydopamine.
Malmfors T; Sachs C
Eur J Pharmacol; 1968 Apr; 3(1):89-92. PubMed ID: 5654676
[No Abstract] [Full Text] [Related]
18. 1-Phenyl-3-(2-thiazolyl)-2-thiourea inhibits melanogenesis via a dual-action mechanism.
Kim YH; Park JI; Myung CH; Lee JE; Bang S; Chang SE; Hwang JS
Arch Dermatol Res; 2016 Sep; 308(7):473-9. PubMed ID: 27278925
[TBL] [Abstract][Full Text] [Related]
19. The effects of 6-hydroxydopamine and guanethidine on peripheral adrenergic nerves in the guinea pig.
O'Donnell SR; Saar N
Eur J Pharmacol; 1974 Oct; 28(2):251-6. PubMed ID: 4607945
[No Abstract] [Full Text] [Related]
20. Selective destruction of adrenergic nerve terminals by chemical analogues of 6-hydroxydopamine.
Tranzer JP; Thoenen H
Experientia; 1973 Mar; 29(3):314-5. PubMed ID: 4708713
[No Abstract] [Full Text] [Related]
[Next] [New Search]
